Improvements Needed: So Says a Performance Audit of $12 Billion California Stem Cell Agency
Succession of Chair, Better Management of Information and More Mentioned
California’s $12 billion stem cell agency needs to do better in several critical areas, ranging from planning for the replacement of its current chair to handling information that is key to its operations as well as the tracking of potential sources of royalties.
That’s according to the latest performance audit of the 17-year-old agency,…
